Table 3.

Most-Common Adverse Events Associated With Afrezza in Clinical Trials¹²,¹⁹

Adverse Event	Rate
Hypoglycemia	67%
Acute bronchospasm in asthmatics	29%
Cough	26% to 29%
Productive cough	2%
Throat pain or irritation	6%
15% or more decrease in FEV1	6%
Headache	5%
Reduced lung function	3%
Bronchitis	3%
Fatigue	2%
Urinary-tract infection	2%

FEV₁ = forced expiratory volume in one second